ClinicalTrials.Veeva

Menu

Tobramycin Exposure From Active Calcium Sulfate Bone Graft Substitute

L

Lausanne University Hospital (CHUV)

Status

Completed

Conditions

Orthopedic Operations

Treatments

Drug: tobramycin

Study type

Observational

Funder types

Other

Identifiers

NCT01938417
Tobramycin cast

Details and patient eligibility

About

This study aimed to assess the systemic absorption and disposition of tobramycin in patients treated with a tobramycin-laden bone graft substitute (Osteoset® T).

Enrollment

12 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult (> or =18 years old) patients
  • Treatment with Osteoset® T

Exclusion criteria

  • Intravenous tobramycin

Trial design

12 participants in 1 patient group

adult patients treated with Osteoset® T (tobramycin sulfate)
Description:
10 g or 20 g of Osteoset® T
Treatment:
Drug: tobramycin

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems